Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Additional Reading from MarketBeat.com
Up Over 200% in 2026, What's Next for AI Stock Aehr Test Systems?Reported by Leo Miller. Published: 4/10/2026. 
Key Points
- AEHR has skyrocketed in 2026, being among the market's top performers.
- The company is generating orders and interest from many corners of the AI infrastructure market, exciting investors.
- The company's momentum in winning deals points to good things ahead, but AEHR's valuation remains a key risk.
- Special Report: Elon’s “Hidden” Company
Aehr Test Systems (NASDAQ: AEHR), a small company in the semiconductor industry, has been indisputably one of the market’s best performers of 2026. During the year, AEHR is one of just five stocks in the Russell 3000 Index to deliver a return of more than 200%. Understanding the scope of the Russell 3000 helps put this into perspective. The index measures the performance of the 3,000 largest U.S. stocks, representing around 98% of the investable U.S. equity market. Because of this, many consider the Russell 3000 to be the most comprehensive gauge of the U.S. stock market. This shows just how big a standout AEHR has been in 2026. The company, which makes equipment to stress-test semiconductors, has announced multiple deals throughout the year. And despite posting mixed results in its latest earnings report, the stock surged by nearly 26% afterward. Let’s dive into what’s driving Aehr’s explosive gains and what investors should consider going forward. Silicon Photonics Deal Boosts AEHR Stock
SpaceX is targeting a $1.75 trillion valuation in what could be the largest IPO in market history - bigger than Saudi Aramco, bigger than Alibaba. The confidential S-1 is expected next month, with the offering slated for June.
One chokepoint company powers the infrastructure Musk can't build around. When the prospectus drops, most investors will already be behind. Get the company name before the S-1 hits the market
Notably, most of Aehr’s 2026 gain has come in a very short period. The stock started the year near $20 and, by late March, had settled near $30. After that, shares more than doubled and eclipsed the $65 mark. March 31 was a significant catalyst, with shares jumping more than 23% after the company announced another key customer win. The company said it had landed a new silicon photonics customer that ordered multiple FOX‑XP systems. Aehr noted the customer is “a global leader in networking products and solutions and a major supplier to the data center optical transceiver market.” This is notable because optical transceivers are being rapidly adopted in artificial intelligence (AI) data centers, which must move ever-larger amounts of data. Companies such as Coherent (NYSE: COHR) and Lumentum (NASDAQ: LITE), which make optical transceivers, have seen strong share-price gains recently. For Aehr, gaining access to this growing market is a meaningful win, and the company says follow-on orders are possible in 2026. Importantly, the customer is buying these systems for both engineering qualification and high-volume production. While firms typically qualify systems before scaling up, this customer is doing both simultaneously—signaling confidence in Aehr’s technology and urgency in deploying it, which increases the likelihood of additional orders. Aehr Looks Poised to See Significant Growth in Fiscal 2027In its latest quarter, Aehr reported revenue of $10.3 million, below analysts’ estimates of $10.85 million. The company's loss during the quarter was $0.05 per share, smaller than the $0.07 analysts expected. The company reiterated guidance for $25 million to $30 million in revenue for the second half of fiscal 2026 (FY2026) and maintained an adjusted loss-per-share outlook of roughly $0.05 to $0.09. Note that Aehr just reported Q3 FY2026 results; its fiscal year is offset from the calendar year. The more compelling story looks further ahead. During the quarter, Aehr recorded bookings of $37.2 million—more than 3.5 times its revenue—strongly indicating larger revenues to come. The company now expects second-half FY2026 bookings to come in at the high end of its $60 million to $80 million range. Aehr’s effective backlog also reached a record $50.9 million, slightly above the high end of its FY2026 revenue guidance. That backlog provides a solid foundation for higher sales in FY2027. AEHR Continues to Show It Is Not a Name to IgnoreOverall, Aehr continues to demonstrate an ability to win customers and secure orders. It has established relationships with an AI-processor developer and silicon-photonics developers—two technologies with strong and growing demand. The company is also in discussions with another AI-processor supplier, multiple high-bandwidth memory companies, and a NAND flash supplier. These memory technologies are among the fastest-growing segments of the AI infrastructure market. It’s hard to label the stock undervalued: AEHR has a market capitalization above $2 billion yet expects to generate at most about $50 million in sales during FY2026. That valuation implies meaningful downside risk given current sales levels. Still, Aehr has clear growth potential in the expanding AI market, and its recent wins make it plausible the company could secure additional deals that push shares higher. Notably, analysts at Craig Hallum upgraded AEHR from a Hold to a Buy after the company’s latest earnings report, setting a $68 price target on the stock—a level shares exceeded soon after. |
0 Response to "We're excited to have you on board"
Post a Comment